Diana Do, MD, professor of ophthalmology and vice chair for clinical affairs, Byers Eye Institute, Stanford University, discusses real-world data presented at the American Academy of Ophthalmology showing…
Richard Gale, MBChB, PhD, professor of ophthalmology, Hull York Medical School, UK, presents long-term real-world outcomes of intravitreal aflibercept 8 mg in patients with diabetic macular edema. Over…
Cataracts are most commonly found in older adults. They can impair vision, how well you see colors, and cause problems with depth perception and balance. Vision problems have…
NEW YORK (Reuters Health) – A large retrospective population-based study of patients from the United Kingdom with type 2 diabetes detected a higher incidence of diabetic macular edema…
NEW YORK (Reuters Health) – An episode of herpes zoster is associated with an increased risk of developing anterior uveitis in the following year, according to the results…
NEW YORK (Reuters Health) – A study conducted at Moorfields Eye Hospital in London, UK, finds that the benefits seen at 1 year with bevacizumab treatment of macular…
NEW YORK (Reuters Health) – A Canadian study confirms an increased risk of uveitis and scleritis in first-time users of oral bisphosphonates. “Patients taking bisphosphonates must be familiar…
NEW YORK (Reuters Health) – Results of two trials indicate that verteporfin photodynamic therapy plus ranibizumab injections is no better than ranibizumab alone for treating subfoveal choroidal neovascularization…
NEW YORK (Reuters Health) – In patients undergoing cataract surgery, topical anesthesia doesn’t provide the same degree of pain relief as regional anesthesia although it’s associated with fewer…
NEW YORK (Reuters Health) – Postcataract surgery endophthalmitis rates in the United States declined slightly between 2003 and 2004, but there is still room for improvement, according to…
NEW YORK (Reuters Health) – For preterm neonates at risk of retinopathy, high-dose vitamin A supplementation started soon after birth produces a significant increase in retinal function, a…
NEW YORK (Reuters Health) – Patients with type 2 diabetes who don’t have retinopathy at baseline have a relatively low risk of developing eye complications during 5 to…
